The antimalarial phytomedicines, Manalaria® and Sirop Kilma®, also frequently used in Kinshasa at the start of pregnancy, would not have previously undergone embryotoxicity tests. This study aims to determine the embryotoxicity of Manalaria® and Sirop Kilma® on mice, Mus musculus. An experimental study in which 54 prepubescent mice were exposed during embryogenesis, including 16 mice to Manalaria®, 20 to Syrup Kilma® and 18 to Quinine. Careful observation by visual inspection and enlarged photography enabled the search for malformations in the exposed mice. As a result, all the mice exposed to the 3 antimalarials did not reveal visible malformations on visual inspection or on enlarged photography. In conclusion, under the experimental conditions of this study, no visible malformation was observed in mice exposed to the two phytomedicines in utero.
Cite this paper
Mbaya, J. K. , Nsonizau, D. M. P. , Nsolani, N. M. and Mesia, G. (2023). Visible Malformations in Mice, Mus musculus Experimentally Exposed in Utero to Antimalarials (Manalaria®, Syrup Kilma® versus Quinine). Open Access Library Journal, 10, e140. doi: http://dx.doi.org/10.4236/oalib.1110140.
Koren, G., Pastuszak, A. and Ito, S. (1998) Drugs in Pregnancy. The New England Journal of Medicine, 338, 1128-1137.
https://doi.org/10.1056/NEJM199804163381607
Briggs, G.G., Freeman, R.K. and Yaffe, S.J. (2008) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 8th Edition, Lippincott Williams & Wilkins, Philadelphia.
Umbers, A.J., Aitken, E.H. and Rogerson, S.J. (2011) Malaria in Pregnancy: Small Babies, Big Problem. Trends in Parasitology, 27, 168-175.
https://doi.org/10.1016/j.pt.2011.01.007
McGready, R., Lee, S.J., Wiladphaingern, J., et al. (2012) Adverse Effects of Falciparum and Vivax Malaria and the Safety of Antimalarial Treatment in Early Pregnancy: A Population-Based Study. The Lancet Infectious Diseases, 12, 388-396.
https://doi.org/10.1016/S1473-3099(11)70339-5
Bell, D. and Winstanley, P. (2004) Current Issues in the Treatment of Uncomplicated Malaria in Africa. British Medical Bulletin, 71, 29-43.
https://doi.org/10.1093/bmb/ldh031
Kangudia Mbaya, J. and Mbanzulu, P.N. (2017) Conformité des prescriptions des antipaludiques au premier trimestre de grossesse par les médecins à Kinshasa. Kisangani Médical Mars, 7, 296-300.
Kangudia Mbaya, J., Mbanzulu, P.N., Mbanzulu Nsolani, N. and Zosuruna M. (2023) Dosage des glycémies à jeun et post-prandiale chez les souris, Mus Musclus. RMSP. (In Press)
Manyando, C., Mkandawire, R., Puma, L., et al. (2010) Safety of Artemether-Lumefantrine in Pregnant Women with Malaria: Results of a Prospective Cohort Study in Zambia. Malaria Journal, 9, Article No. 249.
https://doi.org/10.1186/1475-2875-9-249
Adam, I., Elhassa, E.M., Omer, E.M., Abdulla, M.A., Mahgoub, H.M. and Adam, G.K. (2009) Safety of Artemisinins during Early Pregnancy, Assessed in 62 Sudanese Women. Annals of Tropical Medicine & Parasitology, 103, 205-210.
https://doi.org/10.1179/136485909X398285
Adam, I., Elwasila, E., Ali Mohammed, D.A., Elansari, E. and Elbashir, M.I. (2004) Artemether in the Treatment of Falciparum Malaria during Pregnancy in Eastern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 509-513. https://doi.org/10.1016/j.trstmh.2003.11.008
Adam, I., Idris, H.M. and Elbashir, M.I. (2004) Quinine for Chloroquine-Resistant Falciparum Malaria in Pregnant Sudanese Women in the First Trimester. The Eastern Mediterranean Health Journal, 10, 560-565.
https://doi.org/10.26719/2004.10.4-5.560
Rulisa, S., Kaligirwa, N., Agaba, S., Karema, C., Mens, P.F. and de Vries, P.J. (2012) Pharmacovigilance of Artemether-Lumefantrine in Pregnant Women Followed until Delivery in Rwanda. Malaria Journal, 11, Article No. 225.
https://doi.org/10.1186/1475-2875-11-225
Steketee, R.W., Wirima, J.J., Slutsker, L. and Kh, C.O. (1996) Malaria Treatment and Prevention in Pregnancy: Indications for Use and Adverse Events Associated with Use of Chloroquine or Mefloquine. The American Journal of Tropical Medicine and Hygiene, 55, 50-56. https://doi.org/10.4269/ajtmh.1996.55.50
Deen, J.L., von Seidlein, L., Pinder, M., Walraven, G.E. and Greenwood, B.M. (2001) The Safety of the Combination Artesunate and Pyrimethamine-Sulfadoxine Given during Pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 424-428. https://doi.org/10.1016/S0035-9203(01)90204-4
Sangare, L.R., Weiss, N.S., Brentlinger, P.E., et al. (2011) Patterns of Anti-Malarial drug Treatment among Pregnant Women in Uganda. Malaria Journal, 10, Article No. 152. https://doi.org/10.1186/1475-2875-10-152
Manirakiza, A., Soula, G., Laganier, R., et al. (2011) Pattern of the Antimalarials Prescription during Pregnancy in Bangui, Central African Republic. Malaria Research and Treatment Research, 2011, Article ID: 414510.
https://doi.org/10.4061/2011/414510
Nosten, F., Vincenti, M., Simpson, J., et al. (1999) The Effects of Mefloquine Treatment in Pregnancy. Clinical Infectious Diseases, 28, 808-815.
https://doi.org/10.1086/515183
McGready, R., Cho, T., Cho, J.J., et al. (1998) Artemisinin Derivatives in the Treatment of Falciparum Malaria in Pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 430-433.
https://doi.org/10.1016/S0035-9203(98)91081-1
McGready, R., Cho, T., Keo, N.K., et al. (2001) Artemisinin Antimalarials in Pregnancy: A Prospective Treatment Study of 539 Episodes of Multidrug-Resistant Plasmodium Falciparum. Clinical Infectious Diseases, 33, 2009-2016.
https://doi.org/10.1086/324349
McGready, R., Thwai, K.L., Cho, T., et al. (2002) The Effects of Quinine and Chloroquine Antimalarial Treatments in the First Trimester of Pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 180-184.
https://doi.org/10.1016/S0035-9203(02)90297-X
Singh, N., Mehra, R.K. and Srivastava, N. (2001) Malaria during Pregnancy and Infancy, in an Area of Intense Malaria Transmission in Central India. Annals of Tropical Medicine & Parasitology, 95, 19-29.
https://doi.org/10.1080/00034983.2001.11813611
Phillips-Howard, P.A., Steffen, R., Kerr, L., Vanhauwere, B., Schildknecht, J., Fuchs, E. and Edwards, R. (1998) Safety of Mefloquine and other Antimalarial Agents in the First Trimester of Pregnancy. Journal of Travel Medicine, 5, 121-126.
https://doi.org/10.1111/j.1708-8305.1998.tb00484.x
Schlagenhauf, P., Blumentals, W.A., Suter, P., Regep, L., Vital-Durand, G., Schaerer, M.T. Boutros, M.S., Rhein, H.-G. and Adamcova, M. (2012) Pregnancy and Fetal Outcomes after Exposure to Mefloquine in the Pre- and Periconception Period and during Pregnancy. Clinical Infectious Diseases, 54, e124-e131.
https://doi.org/10.1093/cid/cis215
Pasternak, B. and Hviid, A. (2011) Atovaquone-Proguanil Use in Early Pregnancy and the Risk of Birth Defects. Archives of Internal Medicine, 171, 259-260.
https://doi.org/10.1001/archinternmed.2010.521
Reuvers, N., Vial, T., Schaefer, C., et al. (2012) Pregnancy Outcome after First Trimester Exposure to Malarone (atovaquone-proguanil): A Prospective Case-Series. Birth Defects Research Part A: Clinical and Molecular Teratology, 94, 329.
Wolfe, M.S. and Cordero, J.F. (1985) Safety of Chloroquine in Chemosuppression of Malaria during Pregnancy. British Medical Journal, 290, 1466-1467.
https://doi.org/10.1136/bmj.290.6480.1466
Smoak, B.L., Writer, J.V., Keep, L.W., Cowan, J. and Chantelois, J.L. (1997) The Effects of Inadvertent Exposure of Mefloquine Chemoprophylaxis on Pregnancy Outcomes and Infants of US Army Servicewomen. The Journal of Infectious Diseases, 176, 831-833. https://doi.org/10.1086/517315
Drouin, J., Rock, G. and Jolly, E.E. (1985) Plasmodium Falciparum Malaria Mimicking Autoimmune Hemolytic Anemia during Pregnancy. Canadian Medical Association Journal, 132, 265-267.
Statovci, S., Graevci, S., Berisha, M., Eku, G., Ademaj, I. and Ukeperaj, K. (2015) Late Diagnosis of Anorectal Malformations in Children. Surgical Science, 6, 143-148. https://doi.org/10.4236/ss.2015.63023
